Propafenone efficacy in treatment of atrial fibrillation paroxysms: a placebo-controlled study

In a placebo-controlled study, propafenone efficacy and safety for pharmaceutical cardioversion in atrial fibrillation (AF) paroxysms were studied. The study included 50 patients aged 28-69 years (mean age 53,9+9,7), with AF paroxysms lasting for less than 48 hours. Participants were randomized to p...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Российский кардиологический журнал
المؤلفون الرئيسيون:	Yu. A. Bunin, L. K. Anfalova
التنسيق:	مقال
اللغة:	الروسية
منشور في:	«FIRMA «SILICEA» LLC 2005-12-01
الموضوعات:	atrial fibrillation cardioversion propafenone
الوصول للمادة أونلاين:	https://russjcardiol.elpub.ru/jour/article/view/2343

مواد مشابهة

Comparison of efficacy of pharmacological cardioversion with antazoline and propafenone versus electrical cardioversion in atrial fibrillation during cryoablation
حسب: Konrad Klocek, وآخرون
منشور في: (2024-03-01)

Propafenone efficacy in paroxysmal atrial fibrillation
حسب: V. V. Skibitsky, وآخرون
منشور في: (2004-12-01)

Propafenone efficacy and safety in restoring and maintaining sinus rhythm in patients with recurrent atrial fibrillation: results of the open, prospective placebo-controlled trial
حسب: I. G. Fomina, وآخرون
منشور في: (2005-04-01)

Endothelial function changes in paroxysmal atrial fibrillation and treatment with propafenone
حسب: V. I. Podzolkov, وآخرون
منشور في: (2018-08-01)

Propafenone and amiodarone efficacy in paroxysmal atrial fibrillation treatment
حسب: N. N. Isakova, وآخرون
منشور في: (2006-06-01)

Pharmacological cardioversion of atrial fibrillation paroxysm in elderly and senile patients at prehospital stage
حسب: Andrei V. Syrov
منشور في: (2021-03-01)

Propafenone in restoring sinus rhythm among patients with persistent atrial fibrillation. PROMETEY – an open, multicenter, pilot study performed in the Russian Federation
حسب: I. G. Fomina, وآخرون
منشور في: (2005-08-01)

ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION
حسب: R. D. Kurbanov, وآخرون
منشور في: (2016-01-01)

Comparative Effectiveness of Aksaritmin and Propafenone in the Prevention of Atrial Fibrillation
حسب: Husniddin Sh. Kuchkarov, وآخرون
منشور في: (2023-06-01)

POSSIBLE PREDICTORS OF ATRIAL FIBRILLATION RECURRENCE IN LONG-TERM PROPHYLACTIC PROPAFENONE THERAPY
حسب: R. D. Kurbanov, وآخرون
منشور في: (2015-12-01)

EFFICACY AND SAFETY OF SINUS RHYTHM RESTORATION WITH AMIODARONE AND PROPAFENONE IN OUTPATIENTS, ECONOMIC ASPECTS (BASED ON DATA OF N.A. SEMASHKO NORTHERN MEDICAL CLINICAL CENTER)
حسب: T. A. Istomina, وآخرون
منشور في: (2016-01-01)

Medical therapy with flecainide and propafenone in atrial fibrillation: Long-term clinical experience in the tertiary care setting
حسب: Boldizsar Kovacs, وآخرون
منشور في: (2023-02-01)

Propafenone effect on inotropic myocardial function in patients with recurrent atral fibrillation
حسب: I. G. Fomina, وآخرون
منشور في: (2006-06-01)

Propafenone and lisinopril therapy effectiveness for sinus rhythm maintenance in patients with persistent atrial fibrillation and arterial hypertension (PROMETEY-III)
حسب: R. G. Oganov, وآخرون
منشور في: (1970-01-01)

PHARMACOEPIDEMIOLOGICAL ANALYSIS OF THE TREATMENT OF PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION IN EVERY DAY CLINICAL PRACTICE
حسب: I. V. Graifer, وآخرون
منشور في: (2016-01-01)

Paroxysmal atrial fibrillation: treatment choice
حسب: B. A. Tatarsky
منشور في: (2007-06-01)

THE IMPORTANCE OF EARLY CARDIOVERSION OF PAROXYSMAL ATRIAL FIBRILLATION
حسب: Franc Verovnik
منشور في: (2002-01-01)

EFFECTIVENESS AND SAFETY OF PROPAFENONE (PROPANORM®) AND AMIODARONE (CORDARONE®) IN PATIENTS WITH ATRIAL FIBRILLATION, ARTERIAL HYPERTENSION, CORONARY HEART DISEASE, AND CHRONIC HEART FAILURE WITH INTACT LEFT VENTRICULAR SYSTOLIC FUNCTION
حسب: O. N. Miller, وآخرون
منشور في: (2010-08-01)

Propafenone in restoring sinus rhythm among patients with persistent atrial fibrillation. PROMETEY – an open, multicenter, pilot study performed in the Russian Federation (part II)
حسب: I. G. Fomina, وآخرون
منشور في: (2005-10-01)

PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY
حسب: B. A. Tatarskii
منشور في: (2015-12-01)

Clinical efficacy of potassium canreonate-canrenone in sinus rhythm restoration among patients with atrial fibrillation - a protocol of a pilot, randomized, double -blind, placebo-controlled study (CANREN-AF trial)
حسب: Rafał Dąbrowski, وآخرون
منشور في: (2020-05-01)

Indications for propafenone in the latest ESC guidelines and beyond
حسب: Krisztián Kássa, وآخرون
منشور في: (2025-08-01)

Methods of sinus rhythm restoration in patients with persistent and long-standing persistent atrial fibrillation
حسب: L. M. Kalmanson, وآخرون
منشور في: (2025-06-01)

Present and future of antiarrhythmic therapy for atrial fibrillation: A review
حسب: Aida I. Tarzimanova
منشور في: (2024-11-01)

Current Status of Internal Cardioversion in Atrial Fibrillation.
حسب: Andreas Plewan, وآخرون
منشور في: (2002-04-01)

Acute Management of Paroxysmal Atrial Fibrillation with Intravenous Flecainide plus Oral Beta-Blockers
حسب: Athanasios Kartalis, وآخرون
منشور في: (2024-06-01)

Biomarkers of Atrial Fibrillation Recurrence in Patients with Paroxysmal or Persistent Atrial Fibrillation Following External Direct Current Electrical Cardioversion
حسب: Ozan Demirel, وآخرون
منشور في: (2023-05-01)

THE PROPANORM EFFICACY IN RAPID RELIEF OF SYMPTOMS OF PAROXYSMAL AURICULAR FIBRILLATION
حسب: N. N. Borovkov, وآخرون
منشور في: (2003-10-01)

Frequency of cardioversions as an additional risk factor for stroke in atrial fibrillation – the FinCV-4 study
حسب: Samuli Jaakkola, وآخرون
منشور في: (2022-12-01)

INFLUENCE OF METABOLIC THERAPY ON LIFE QUALITY IN PATIENTS WITH ATRIAL FIBRILLATION PAROXYSMS
حسب: I.M. Fushtey, وآخرون
منشور في: (2022-09-01)

CARDIOVERSION WITH BI- AND MONOPHASE DEFIBRILLATORS IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION
حسب: V. A. Lusov, وآخرون
منشور في: (2010-02-01)

Aggressive Rhythm Control Strategy in Atrial Fibrillation Patients Presenting at the Emergency Department: The HEROMEDICUS Study Design and Initial Results
حسب: Dimitrios Tsiachris, وآخرون
منشور في: (2024-03-01)

Efficiency of Electrical Cardioversion of Paroxysmal Atrial Fibrillation in the Use of Bipolar QuasiSinusoidal Impulse in Patients with Coronary Heart Disease
حسب: V. A. Vostrikov, وآخرون
منشور في: (2014-06-01)

Effectiveness of Class IC Antiarrhythmics in Patients with Paroxysmal Form of Atrial Fibrillation in Absence of Structural Heart Disease
حسب: D. A. Tsaregorodtsev, وآخرون
منشور في: (2023-05-01)

Intravenous Cavutilide for Pharmacological Conversion of Paroxysmal and Persistent Atrial Fibrillation in Patients with Heart Failure
حسب: Maria M. Beliaeva, وآخرون
منشور في: (2023-12-01)

Prevention of atrial fibrillation episodes in patients with chronic heart failure: a new approach to the old problem
حسب: Yu. M. Pozdnyakov, وآخرون
منشور في: (1970-01-01)

MR-proANP, sST2, BNP and sinus rhythm maintenance 1 year after electrical cardioversion for atrial fibrillation
حسب: Marc Badoz, وآخرون
منشور في: (2025-08-01)

Prevalence and risk factors associated with decompensated heart failure after successful elective cardioversion for atrial fibrillation and atrial flutter
حسب: Christina Healy, وآخرون
منشور في: (2024-11-01)

Predictors of time to conversion of new‐onset atrial fibrillation to sinus rhythm with amiodarone therapy
حسب: Ihsan Dursun, وآخرون
منشور في: (2020-08-01)

Serial electrical cardioversion for refractory atrial fibrillation with rapid ventricular response post ablation
حسب: Katherine Liu, وآخرون
منشور في: (2025-10-01)